BCFA suppresses LPS induced IL-8 mRNA expression in human intestinal epithelial cells

Area of Science:

• Gastroenterology
• Immunology
• Nutritional Science

Background:

• Branched chain fatty acids (BCFA) are common dietary fats and gut constituents.
• Polyunsaturated fatty acids (PUFA) are linked to reduced inflammatory bowel disease (IBD) risk.
• The impact of BCFA on inflammation remains largely uncharacterized.

Purpose of the Study:

• To investigate the effects of BCFA on pro-inflammatory markers in human intestinal cells.
• To compare the efficacy of different BCFA isomers and omega-3 fatty acids (DHA, EPA) on inflammation.

Main Methods:

• Caco-2 human intestinal epithelial cells were pre-treated with specific BCFA, DHA, or EPA.
• Cells were subsequently stimulated with lipopolysaccharide (LPS) to induce inflammation.
• Interleukin-8 (IL-8) production and Toll-like receptor 4 (TLR-4) expression were measured.

Main Results:

• Both anteiso- and iso-BCFA significantly reduced IL-8 production in LPS-stimulated Caco-2 cells.
• Anteiso-BCFA demonstrated greater suppression of IL-8 compared to iso-BCFA.
• BCFA were less effective than DHA or EPA in reducing IL-8.
• BCFA treatment led to decreased expression of TLR-4 on activated Caco-2 cells.

Conclusions:

• BCFA can reduce pro-inflammatory marker production in human intestinal cells.
• These findings suggest a potential role for BCFA in modulating gut inflammation.
• BCFA represent a novel class of dietary components with anti-inflammatory properties in the gut.